Skip to content

Category Archives: Delphi Ventures

V.C.s lead Spin-Off of Boston Scientific Unit > TriVascular2 > Divest nonstrategic assets > $65 million from previous and new investors > Series A preferred round to finance spinout > Programs Boston Scientific suspended in June 2006 > MPM Capital > New Enterprise Associates > Delphi Ventures > Kearny Venture Partners > Complete clinical development > Endovascular aneurysm repair EVAR > Stent-graft

Thursday, April 3, 2008

Does TriVascular address an opportunity that justifies the new investments by MPM Capital and NEA? Is it feasible to address a broader patient population requiring endovascular repair of aortic aneurysms with the novel stent-graft from TriVascular? Will these patients have a safe and permanent alternative to open surgical repair?

IIP > Read on here…
TriVascular2, a company […]

Filed in Stent graft migration following endovascular aneurysm r, Aorfix Dacron stent-graft, Type I endoleaks, Aneurysm rupture, Paraplegia secondary to spinal cord ischaemia, Endovascular techniques prone to similar complications, Surgical revision, GORE EXCLUDER AAA Endoprosthesis, Stent grafts have a tendency to migrate, Fixation of stent grafts, Endoleaks, Keep the graft in place, Life Line Screening, Benefit from screening, Complication of stent-graft repair, Men in England are to be offered AAA screening, New Enterprise Associates, MPM Capital, Kearny Venture Partners, Complete clinical development, Stent-graft, Endovascular aneurysm repair EVAR, Divest nonstrategic assets, Finance spinout, Spin-Off, Delphi Ventures, Boston Scientific Unit, TriVascular2, Series A preferred round, Medical devices to treat aneurysms AAA, Stent graft fixation product, Stent Stapler, Watchful waiting, Treatment of aneurysms, Open aneurysm repair, Surgical aneurysm repair, Endoaneurysmorrhaphy, Elective surgical treatment of AAA, Albert Einstein, Sudden severe back or abdominal pain, Ultrasound screening, Rupture of an abdominal aortic aneurysm, Abdominal aortic aneurysm AAA, Endovascular stent graft, Risk of developing AAA, Silent killer, Totally laparoscopic AAA replacement, Larger aneurysms can leak or rupture, Free screening for AAA, Ascending aortic aneurysm, Welcome to Medicare physical, Screen the aorta, Stapling may replace stitching, Scanning and visualizing the aorta, Simple $50 ultrasound scan, Stent-graft technology under serious scrutiny, Need for reintervention, Endovascular stenting, Long-term graft performance, AAA stent-graft device, Subsidiary of a major stent-graft company, Warning letter, Ideas For Surgery News | Comments (0)

Safe Veres Needle Technique > Aragon Surgical LapCap > Establish Fast And Safe Pneumoperitoneum In Laparoscopic Surgery > Medical Device Startup > Aragon Surgical Inc > Raised $25 Million Venture Capital In A Series B Round

Monday, February 11, 2008

Will Aragon Surgical Inc be successful in developing a platform of surgical products which offer unique value propositions to surgeons, patients, and operating facilities? Will Aragon have five products on the market within two years? Will Aragon’s mission statement to save money and increase margins for hospitals prevail and how will the company reduce costs […]

Filed in Stanford University Medical School, Viability of technology, Radio frequency technology, Onset Ventures, Integral Capital Partners, Delphi Ventures, Early regulatory trials, VeriSure Inc, Increasing focus of hospitals, Improve patient outcomes, Reducing operating room time, Reducing costs by speeding up surgeries, All-stock deal from angel investors, Radio frequency energy to create and seal incisions, Bay City Capital, Unique value propositions, Medical Device Company, Establish fast and safe Pneumoperitoneum, Venture Capital Financing, Laparoscopic technique, Laparoscopic tools, Laparoscopy, Aragon Surgical LapCap, Aragon Surgical Inc, Tools that seal and divide tissue, Cutting time, Safe Verres Needle Technique, Aragon Surgical LapCap, Medical device startup, Raised $25 million in a Series B round, Laparoscopy Laparoscopic | Comments (0)